Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Castle

Showing results (341-350 of 363) with videos related to

Pageof 37
Sort By:
CNS Drugs|September 13, 2022
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewNiloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, et al.
CNS Spectrums|June 24, 2021
Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot studyJerome Sarris, Gerard J Byrne, Georgina Oliver, et al.
Contemporary Clinical Trials|September 15, 2020
The assertive cardiac care trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care settingMatthew Lewis, Patty Chondros, Cathrine Mihalopoulos, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
BMC Psychiatry|February 14, 2025
Strengthening the delivery of integrated care for individuals experiencing serious mental illness within mental health settings: a qualitative description of health provider perspectivesMunazzah Ambreen, Christopher Canning, Brian Lo, et al.
Frontiers in Psychiatry|June 20, 2022
Adapting Peer Researcher Facilitated Strategies to Recruit People Receiving Mental Health Services to a Tobacco Treatment TrialAmanda L Baker, Kristen McCarter, Lisa Brophy, et al.
Frontiers in Psychiatry|February 21, 2025
"Holding on to Hope": follow up qualitative findings of a tobacco treatment intervention for people experiencing mental health conditionsTessa-May Zirnsak, Kristen McCarter, Melissa L McKinlay, et al.
Journal of Psychiatric Research|June 27, 2025
Empirically informed symptom severity cutoffs for body dysmorphic disorderDavid Mataix-Cols, Philip Andersson, Daniel Rautio, et al.
Schizophrenia Research|August 3, 2019
Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international surveyShunya Kurokawa, Taishiro Kishimoto, Kuan-Pin Su, et al.
The Australian and New Zealand Journal of Psychiatry|June 24, 2023
'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health servicesAmanda L Baker, Kristen McCarter, Alyna Turner, et al.
Pageof 37

Showing results (341-350 of 363) with videos related to

Sort By:
Pageof 37
CNS Drugs|September 13, 2022
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic ReviewNiloufar Pouyan, Zahra Halvaei Khankahdani, Farnaz Younesi Sisi, et al.
CNS Spectrums|June 24, 2021
Treatment of refractory obsessive-compulsive disorder with nutraceuticals (TRON): a 20-week, open label pilot studyJerome Sarris, Gerard J Byrne, Georgina Oliver, et al.
Contemporary Clinical Trials|September 15, 2020
The assertive cardiac care trial: A randomised controlled trial of a coproduced assertive cardiac care intervention to reduce absolute cardiovascular disease risk in people with severe mental illness in the primary care settingMatthew Lewis, Patty Chondros, Cathrine Mihalopoulos, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
BMC Psychiatry|February 14, 2025
Strengthening the delivery of integrated care for individuals experiencing serious mental illness within mental health settings: a qualitative description of health provider perspectivesMunazzah Ambreen, Christopher Canning, Brian Lo, et al.
Frontiers in Psychiatry|June 20, 2022
Adapting Peer Researcher Facilitated Strategies to Recruit People Receiving Mental Health Services to a Tobacco Treatment TrialAmanda L Baker, Kristen McCarter, Lisa Brophy, et al.
Frontiers in Psychiatry|February 21, 2025
"Holding on to Hope": follow up qualitative findings of a tobacco treatment intervention for people experiencing mental health conditionsTessa-May Zirnsak, Kristen McCarter, Melissa L McKinlay, et al.
Journal of Psychiatric Research|June 27, 2025
Empirically informed symptom severity cutoffs for body dysmorphic disorderDavid Mataix-Cols, Philip Andersson, Daniel Rautio, et al.
Schizophrenia Research|August 3, 2019
Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international surveyShunya Kurokawa, Taishiro Kishimoto, Kuan-Pin Su, et al.
The Australian and New Zealand Journal of Psychiatry|June 24, 2023
'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health servicesAmanda L Baker, Kristen McCarter, Alyna Turner, et al.
Pageof 37